BioCentury
ARTICLE | Company News

Bristol-Myers biomanufacturing news

June 5, 2006 7:00 AM UTC

BMY will build a large-scale biologics manufacturing facility in Devens, Mass., in part to help meet expected demand for rheumatoid arthritis (RA) drug Orencia abatacept. The company expects to begin...